Teton Advisors Inc. Cuts Holdings in Orthofix Medical Inc. (NASDAQ:OFIX)

Teton Advisors Inc. trimmed its holdings in shares of Orthofix Medical Inc. (NASDAQ:OFIX) by 11.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,500 shares of the medical device company’s stock after selling 3,000 shares during the quarter. Teton Advisors Inc. owned approximately 0.06% of Orthofix Medical worth $303,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the business. Gladius Capital Management LP increased its position in shares of Orthofix Medical by 55.2% during the fourth quarter. Gladius Capital Management LP now owns 2,841 shares of the medical device company’s stock worth $38,000 after purchasing an additional 1,010 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Orthofix Medical by 30.4% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,516 shares of the medical device company’s stock worth $101,000 after purchasing an additional 1,752 shares in the last quarter. State Board of Administration of Florida Retirement System acquired a new position in shares of Orthofix Medical during the third quarter worth $130,000. Arizona State Retirement System acquired a new position in shares of Orthofix Medical during the fourth quarter worth $138,000. Finally, Teza Capital Management LLC acquired a new position in shares of Orthofix Medical during the third quarter worth $133,000. 89.76% of the stock is owned by hedge funds and other institutional investors.

Orthofix Medical Stock Performance

NASDAQ:OFIX traded up $0.21 during mid-day trading on Thursday, hitting $13.24. The company’s stock had a trading volume of 165,520 shares, compared to its average volume of 398,964. Orthofix Medical Inc. has a 1 year low of $9.57 and a 1 year high of $21.60. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.54 and a quick ratio of 1.20. The stock has a market cap of $495.31 million, a price-to-earnings ratio of -3.15 and a beta of 1.06. The business’s fifty day moving average is $13.63 and its two-hundred day moving average is $12.98.

Orthofix Medical (NASDAQ:OFIX) last posted its quarterly earnings results on Tuesday, March 5th. The medical device company reported ($0.59) EPS for the quarter, beating the consensus estimate of ($0.60) by $0.01. Orthofix Medical had a negative net margin of 20.28% and a negative return on equity of 10.63%. The company had revenue of $200.42 million for the quarter. Analysts anticipate that Orthofix Medical Inc. will post -1.51 EPS for the current fiscal year.

Analysts Set New Price Targets

OFIX has been the topic of several research reports. JMP Securities reissued a “market perform” rating on shares of Orthofix Medical in a research report on Monday, April 22nd. Roth Mkm upped their target price on Orthofix Medical from $12.00 to $15.00 and gave the company a “neutral” rating in a research report on Thursday, March 7th. Finally, StockNews.com downgraded Orthofix Medical from a “hold” rating to a “sell” rating in a research report on Wednesday, March 6th. One research analyst has rated the stock with a sell rating and four have given a hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $15.50.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.